The efficacy of brusatol as a chemotherapeutic agent in pancreatic cancer and its relevance to potential chemoresistance conferred by Nrf2

Authors :: Pedro A. Perez-Mancera
Susana Gayon
Lawrence N. Barrera
Dylan P. Williams
Ian M. Copple
William Greenhalf
Christopher E. Goldring
Eithne Costello
Source :: Pancreatology. 18:S149
Publication Year :: 2018
Publisher :: Elsevier BV, 2018.

Subjects :: Hepatology
business.industry
Endocrinology, Diabetes and Metabolism
Pancreatic cancer
Gastroenterology
Cancer research
Medicine
Relevance (information retrieval)
business
medicine.disease

Tools